Influence of of Cream With the Silver Fir Wood Extract (Belinal) on Skin
Placebo Controlled Study of Influence of Cream With the Silver Fir (Abies Alba) Wood Extract on the Skin
1 other identifier
interventional
10
0 countries
N/A
Brief Summary
Objective of the study is to determine the influence of the cream with Silver fir wood (Abies alba) extract (Belinal) on the skin parameters and functions in comparison to the placebo cream. 10 healthy female subjects will use the test cream on one half and placebo cream on the other half of the face and of the gluteal part twice a day for 12 weeks. Various face skin parameters will be evaluated before the cream use (the baseline), after 6 and after 12 weeks of the cream use. To evaluate the photoprotective potential of Belinal the minimal erythema dose (MED) will be determined before (the baseline) and after 12 weeks of the cream use at the gluteal area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 10, 2015
CompletedFirst Posted
Study publicly available on registry
November 11, 2015
CompletedMarch 8, 2016
November 1, 2015
4 months
November 10, 2015
March 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Improvement of photoprotective function of the skin
Minimal erythema dose (MED) of the skin will be determined. Skin on the gluteal part of the body will be exposed to 10 different doses of UVB light and 24 hours after exposure MED will be determined. Higher MED indicates better photoprotective function of the skin.
up to 12 weeks of the supplementation
Improvement of the dermis structure
Ultrasound (US) images of the dermis will be taken and intensity of the dermis determined. Higher intensity of the dermis US images indicates improvement of the collagen and elastin network.
up to 12 weeks of Belinal cream use
Secondary Outcomes (6)
Reduction of the area of the periorbital facial wrinkles
6 and 12 weeks of Belinal cream use
Reduction of the volume of the periorbital facial wrinkles
6 and 12 weeks of Belinal cream use
Reduction of trans-epidermal water loss
6 and 12 weeks of Belinal cream use
Improved skin hydration
6 and 12 weeks of Belinal cream use
Improved skin elasticity
6 and 12 weeks of Belinal cream use
- +1 more secondary outcomes
Study Arms (2)
Placebo cream
PLACEBO COMPARATORCream with 0% Silver fir wood extract (Belinal)
Belinal cream
ACTIVE COMPARATORCream with 2% Silver fir wood extract (Belinal)
Interventions
Subjects will use placebo cream twice per day for 12 weeks on one half of the face and of the gluteal area.
Subjects will use Belinal cream twice per day for 12 weeks on the other half of the face and of the gluteal area.
Eligibility Criteria
You may qualify if:
- Signs of skin aging (mimic wrinkles/ fine lines/ poor skin tone/ photoaged skin),
- Phototype II and III.
You may not qualify if:
- Allergy to ingredients of tested products
- Diagnosed diabetes
- Thyroid disease
- Inflammatory dermatoses
- Regular use of dietary supplements 6 months or less before start of the study,
- Invasive rejuvenation treatments (botox injections, hyaluronic acid fillers, needle rollers, needle mesotherapy, etc.) 6 months or less prior to start of the study,
- Non-invasive rejuvenation treatments (radiofrequency, electrotherapy, ultrasound therapy, no-needle mesotherapy, etc.) 3 months or less prior to start of the study,
- Regular, at least 14 day use of anti-aging cosmetic products containing peptides/ polyphenols/ stem cells extracts/ vitamins in high concentration/ AHAs/ BHAs/ vitamin A or its derivatives) three months or less prior to start of the study,
- Gluteal hyperpigmentation,
- Expected sunbathing (also in solariums) within the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VIST - Faculty of Applied Scienceslead
- Abies Labs d.o.o.collaborator
Study Officials
- STUDY CHAIR
Janko Zmitek, PhD
VIST - Faculty of Applied Sciences
- STUDY DIRECTOR
Katja Zmitek, PhD
VIST - Faculty of Applied Sciences
- PRINCIPAL INVESTIGATOR
Nataša Tavčar, BSc
VIST - Faculty of Applied Sciences
- PRINCIPAL INVESTIGATOR
Tina Pogačnik, BSc
VIST - Faculty of Applied Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2015
First Posted
November 11, 2015
Study Start
March 1, 2015
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
March 8, 2016
Record last verified: 2015-11